A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01692457
Recruitment Status : Withdrawn (The company decided to cancel the study in conformity with Philippine FDA Circular 2013-004)
First Posted : September 25, 2012
Last Update Posted : December 2, 2015
Information provided by (Responsible Party):
Janssen Pharmaceutica

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2016
  Estimated Study Completion Date : July 2016